Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice-Reference-Cited by-同舟云学术

Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice

Published:2023-04 Issue:4 Volume:5 Page:100651
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Seedorf Klaus^ORCID,Weber Csaba^ORCID,Vinson Cedric^ORCID,Berger Sylvie,Vuillard Laurent-Michel,Kiss Arpad,Creusot Stephanie,Broux Olivier,Geant Anne,Ilic Catherine,Lemaitre Karine,Richard Johann,Hammoutene Adel^ORCID,Mahieux Julien,Martiny Virginie,Durand Didier,Melchiore Fabien^ORCID,Nyerges Miklos^ORCID,Paradis Valerie,Provost Nicolas,Duvivier Valérie,Delerive Philippe^ORCID

Funder

Institut de Recherches Servier

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference76 articles.

1. Nonalcoholic fatty liver disease;Brunt;Nat Rev Dis Prim,2015

2. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis;Diehl;N Engl J Med,2017

3. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis;Younossi;J Hepatol,2019

4. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

5. Mechanisms and disease consequences of nonalcoholic fatty liver disease;Loomba;Cell,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis;Life Sciences;2024-06

2. Ablation of Brg1 in fibroblast/myofibroblast lineages attenuates renal fibrosis in mice with diabetic nephropathy;Life Sciences;2024-05

3. The Role of Nrf2 in Exercise Improving of NAFLD;PROG BIOCHEM BIOPHYS;2024

4. Tiliroside attenuates acute kidney injury by inhibiting ferroptosis through the disruption of NRF2-KEAP1 interaction;Phytomedicine;2024-04

5. Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis;Biochemical Pharmacology;2024-02